Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers.
about
Levels of soluble E-cadherin in breast, gastric, and colorectal cancersAbnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer.Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expressionInflammation-induced desmoglein-2 ectodomain shedding compromises the mucosal barrier.Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniquesRUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype.Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.sEcad and EGF Levels Increased in Urine of Non-ferrous Metal Workers and Medium of Uroepithelial Cell Line Treated by Arsenic.Cadherins function during the collective cell migration of Xenopus Cranial Neural Crest cells: revisiting the role of E-cadherin.Dual control of pcdh8l/PCNS expression and function in Xenopus laevis neural crest cells by adam13/33 via the transcription factors tfap2α and arid3aThe ectodomain of cadherin-11 binds to erbB2 and stimulates Akt phosphorylation to promote cranial neural crest cell migration.Roles of RUNX in Hippo Pathway Signaling.Cut loose and run: The complex role of ADAM proteases during neural crest cell development.
P2860
Q27012638-545F4F7F-47E6-4483-B4FF-7FF9BF4BA2A5Q34789523-9D54FF7C-C06A-429D-9517-8C6CE8AB30C2Q35550160-F5F01399-8651-4C5F-9440-BD2032142CCFQ36058429-E9DBE566-D0D5-425E-B3BE-DF8541CB6360Q36107543-892D77D1-157C-4FBF-B5FF-AF1387EDFE0CQ36413997-7B80BD00-657F-4F16-BECE-3EEF248C40EEQ36462450-CD54233D-B8A2-424D-84EA-274B774907F2Q37625774-7BC3857A-3425-435A-A685-78983858CB9EQ38679713-26472398-09AC-4973-9BA9-069A76E1F902Q38694636-59A9394B-AB9D-4737-A775-29AD84286FBCQ39280745-70FEC3FB-4F69-41EA-BD3E-51DDCCF62A01Q41720457-E44F4ECA-CFF1-454D-A98C-51B5BDDC5140Q47161792-07E322EC-9F70-4F13-A3B5-BCD049A5F355Q47944350-B1B886DB-7A91-4F6D-BB39-F159E45D3933Q52373579-E1D0951E-1D12-46C1-B825-3751C6A09346
P2860
Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Soluble-E-cadherin activates H ...... and TNBC human breast cancers.
@ast
Soluble-E-cadherin activates H ...... and TNBC human breast cancers.
@en
type
label
Soluble-E-cadherin activates H ...... and TNBC human breast cancers.
@ast
Soluble-E-cadherin activates H ...... and TNBC human breast cancers.
@en
prefLabel
Soluble-E-cadherin activates H ...... and TNBC human breast cancers.
@ast
Soluble-E-cadherin activates H ...... and TNBC human breast cancers.
@en
P2093
P2860
P356
P1476
Soluble-E-cadherin activates H ...... and TNBC human breast cancers.
@en
P2093
M Kerry O'Banion
Robert Clarke
Sabine M Brouxhon
Stephanos Kyrkanides
Stephen Byers
Xiaofei Teng
P2860
P304
P356
10.1002/MC.22048
P577
2013-06-18T00:00:00Z